News & Updates

Show Multimedia Only

Does enrolment in clinical trials improve survival in patients with multiple myeloma?

06 Dec 2021

Enrolment in clinical trials does not seem to increase survival among patients with multiple myeloma, a recent study has found.

Does enrolment in clinical trials improve survival in patients with multiple myeloma?

06 Dec 2021

PD-1 inhibitors outperform chemo in second-line treatment of advanced oesophageal cancer

06 Dec 2021

In the second-line treatment of patients advanced oesophageal cancer, the use of programmed cell death 1 (PD-1) inhibitors yields more favourable outcomes than chemotherapy across multiple patient subgroups, according to the results of a meta-analysis.

PD-1 inhibitors outperform chemo in second-line treatment of advanced oesophageal cancer

06 Dec 2021

Cisplatin-based chemotherapy boosts survival in muscle-invasive bladder cancer

05 Dec 2021

Cisplatin-based adjuvant chemotherapy confers substantial survival benefit in patients with muscle-invasive bladder cancer, reports a recent meta-analysis of randomized controlled trials (RCT).

Cisplatin-based chemotherapy boosts survival in muscle-invasive bladder cancer

05 Dec 2021

Long-term renal function decline common following radical cystectomy for bladder cancer

05 Dec 2021

Renal function considerably decreases over the long term for most bladder cancer patients who underwent radical cystectomy, a study has found.

Long-term renal function decline common following radical cystectomy for bladder cancer

05 Dec 2021

Actual body weight dosing of temozolomide offers survival benefits in glioblastoma

03 Dec 2021

Temozolomide administered to patients with glioblastoma at full actual body weight dosing during the concurrent phase is necessary to achieve a median overall survival (OS) that is similar to that seen in a previous trial, according to a recent study.

Actual body weight dosing of temozolomide offers survival benefits in glioblastoma

03 Dec 2021

MiR-146a levels show good prognostic, diagnostic value in ALL

02 Dec 2021

The circulating levels of microRNA (miR)-146a is a potential noninvasive biomarker for the diagnosis and prognosis of acute lymphoblastic leukaemia (ALL) in both paediatric and adult patients, a recent study has found.

MiR-146a levels show good prognostic, diagnostic value in ALL

02 Dec 2021

Does statin affect performance of PSA screening?

02 Dec 2021 by

Prostate-specific antigen (PSA) screening was associated with similar decrease in incidence of advanced prostate cancer (PCa) among statin users vs nonusers, but less detection of low-grade localized tumours in the former than the latter — indicating that statin does not compromise the benefits of PSA-based screening while also conferring the benefit of less overdiagnosis of low-risk tumours.

Does statin affect performance of PSA screening?

02 Dec 2021

Is docetaxel helpful in metastatic hormone-sensitive prostate cancer?

02 Dec 2021

Treatment with docetaxel appears beneficial in patients with low- and high-burden metastatic hormone-sensitive prostate cancer, a study has shown. However, no consistent differences for overall survival are seen in subgroup analyses as regards volume of metastatic disease.

Is docetaxel helpful in metastatic hormone-sensitive prostate cancer?

02 Dec 2021

Nivolumab a potential treatment for metastatic thymic epithelial tumours

02 Dec 2021

Nivolumab is a promising therapy for patients with thymic epithelial tumours who have received multiple-line treatments, suggests a study. However, the high rate of severe toxicities specifies a need to find out a reliable marker to predict patients who will derive benefit or exhibit toxicity.

Nivolumab a potential treatment for metastatic thymic epithelial tumours

02 Dec 2021

Initiation of biosimilar pegfilgrastim helps reduce cost, financial pressure on healthcare system

01 Dec 2021

The introduction of pegfilgrastim biosimilar may lower the cost and lessen some of the financial pressure on the healthcare system, suggests a study in France.

Initiation of biosimilar pegfilgrastim helps reduce cost, financial pressure on healthcare system

01 Dec 2021

News & Updates

Filter by Specialty:

Specialty:

Does enrolment in clinical trials improve survival in patients with multiple myeloma?

Does enrolment in clinical trials improve survival in patients with multiple myeloma?

PD-1 inhibitors outperform chemo in second-line treatment of advanced oesophageal cancer

PD-1 inhibitors outperform chemo in second-line treatment of advanced oesophageal cancer

Cisplatin-based chemotherapy boosts survival in muscle-invasive bladder cancer

Cisplatin-based chemotherapy boosts survival in muscle-invasive bladder cancer

Long-term renal function decline common following radical cystectomy for bladder cancer

Long-term renal function decline common following radical cystectomy for bladder cancer

Actual body weight dosing of temozolomide offers survival benefits in glioblastoma

Actual body weight dosing of temozolomide offers survival benefits in glioblastoma

MiR-146a levels show good prognostic, diagnostic value in ALL

MiR-146a levels show good prognostic, diagnostic value in ALL

Does statin affect performance of PSA screening?

Does statin affect performance of PSA screening?

Is docetaxel helpful in metastatic hormone-sensitive prostate cancer?

Is docetaxel helpful in metastatic hormone-sensitive prostate cancer?

Nivolumab a potential treatment for metastatic thymic epithelial tumours

Nivolumab a potential treatment for metastatic thymic epithelial tumours

Initiation of biosimilar pegfilgrastim helps reduce cost, financial pressure on healthcare system

Initiation of biosimilar pegfilgrastim helps reduce cost, financial pressure on healthcare system